• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis

cafead

Administrator
Staff member
  • cafead   Sep 29, 2022 at 10:12: AM
via This approval makes Dupixent the first and only medicine available in the US for the treatment of prurigo nodularis, a chronic and debilitating skin disease.

article source
 

<